Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites | NYU Langone Health

Go Back to All Clinical Trials

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Smoking Cessation
Age: Between 18 years - 100 years
Gender: Male or Female

Other Inclusion Criteria:

1) Patients who are seeking baseline LDCT lung cancer screening and have at least a 30 pack-year history of smoking. 2) Patients who are currently a smoker, defined as self-reported cigarette smoking (some days, every day) within the past 30 days.

You may not be eligible for this study if the following are true:

1) Patients who have NRT, which is medically contraindicated (e.g., recent heart attack, unstable angina). 2) Patients who are smokers, receiving other tobacco treatment services or have used cessation medications (NRT, bupropion, varenicline) within the past month.